A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
Clinical trial NCT07632274 · RECRUITING
Trial details
- NCT number
- NCT07632274
- Sponsor
- HALEON
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-19
- Primary completion
- 2026-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.